Melissa J LaBonte (Melissa LaBonte Wilson)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Radical Prostatectomy

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

Molecular cancer research : MCR

NPJ breast cancer

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Shauna McClelland, Pamela J Maxwell, Cristina M Branco, Simon T Barry, Cath Eberlein, Melissa J LaBonte
Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance. Cancers 16 (16) (2024)
Hadil Sulieman, Alexandra Emerson, Peter M Wilson, Karl A Mulligan, Robert D Ladner, Melissa J LaBonte
Harnessing nucleotide metabolism and immunity in cancer: a tumour microenvironment perspective. The FEBS journal (2024)
Shauna McClelland, Pamela J Maxwell, Cristina M Branco, Simon T Barry, Cath Eberlein, Melissa J LaBonte
Targeting IL-8 and Its Receptors in Prostate Cancer: Inflammation, Stress Response, and Treatment Resistance. Cancers 16 (16) (2024)
Lanshan Huang, Sarah J Winter, Linnea T Olsson, Alina M Hamilton, Sophia R Halliday, Erin L Kirk, Laura Farnan, Adrian Gerstel, Stephanie G Craig, Stephen P Finn, Melissa J LaBonte, Suneil Jain, Melissa A Troester, Eboneé N Butler, Jeannette T Bensen, Sara E Wobker, Emma H Allott
Associations of prostate tumor immune landscape with vigorous physical activity and prostate cancer progression. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
Hajrah Khawaja, Rebecca Briggs, Cheryl H Latimer, Mustasin Rassel, Daryl Griffin, Lyndsey Hanson, Alberto Bardelli, Federica Di Nicolantonio, Simon S McDade, Christopher J Scott, Shauna Lambe, Manisha Maurya, Andreas U Lindner, Jochen H M Prehn, Jose Sousa, Chris Winnington, Melissa J LaBonte, Sarah J Ross, Sandra Van Schaeybroeck
Bcl-xL is a key mediator of apoptosis following KRASG12C inhibition in KRASG12C mutant colorectal cancer. Molecular cancer therapeutics (2022)
Lanshan Huang, Melissa J LaBonte, Stephanie G Craig, Stephen P Finn, Emma H Allott
Inflammation and Prostate Cancer: A Multidisciplinary Approach to Identifying Opportunities for Treatment and Prevention. Cancers 14 (6) (2022)
Pamela J Maxwell, Melanie McKechnie, Christopher W Armstrong, Judith M Manley, Chee Wee Ong, Jenny Worthington, Ian Geoffrey Mills, Daniel B Longley, James P Quigley, Amina Zoubeidi, Johann S de Bono, Elena Deryugina, Melissa J LaBonte, David J J Waugh
Attenuating Adaptive VEGF-A and IL8 Signaling Restores Durable Tumor Control in AR Antagonist-Treated Prostate Cancers. Molecular cancer research : MCR 20 (6) (2022)
Craig Davison, Roisin Morelli, Catherine Knowlson, Melanie McKechnie, Robbie Carson, Xanthi Stachtea, Kylie A McLaughlin, Vivien E Prise, Kienan I Savage, Richard H Wilson, Karl A Mulligan, Peter M Wilson, Robert D Ladner, Melissa J LaBonte
Targeting nucleotide metabolism enhances the efficacy of anthracyclines and anti-metabolites in triple-negative breast cancer. NPJ breast cancer 7 (1) (2021)